AI
TELA icon

Atom Investors’s TELA Bio TELA Stock Holding History

Atom Investors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,795
Closed -$83K – 813
2025
Q2 		$83K Sell
42,795
-5,315
-11% -$6.96K 0.01% 562
2025
Q1 		$58.7K Buy
+48,110
New +$118K 0.01% 463
2024
Q3 		– Sell
-64,359
Closed -$302K – 599
2024
Q2 		$302K Buy
64,359
+28,746
+81% +$152K 0.03% 374
2024
Q1 		$202K Buy
35,613
+10,419
+41% +$68.7K 0.03% 484
2023
Q4 		$167K Buy
25,194
+9,620
+62% +$55.6K 0.03% 412
2023
Q3 		$125K Buy
15,574
+1,362
+10% +$12.7K 0.03% 401
2023
Q2 		$144K Buy
+14,212
New +$145K 0.05% 261

Other funds holding TELA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Atom Investors's TELA Position: Q3 2025 in Review

Atom Investors sold out of TELA Bio (TELA) in Q3 2025, closing a stake of 42,795 shares — an estimated $83K sold.

Atom Investors first reported a position in TELA in Q2 2023 and held it in 7 quarters. The position peaked at $302K in Q2 2024. 40 funds tracked by Wall St. Rank hold TELA as of Q3 2025.

  • Atom Investors reported no remaining TELA Bio position as of Q3 2025 after selling out during the quarter.
  • Atom Investors sold 42,795 TELA Bio shares in Q3 2025, an estimated $83K.
  • Atom Investors first reported a position in TELA Bio in Q2 2023 and held it in 7 quarters.
  • Atom Investors's TELA Bio position peaked at $302K in Q2 2024.
  • 40 funds tracked by Wall St. Rank held TELA Bio as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.